OR WAIT null SECS
Todd D. Hatajik is a scientist at Pfizer Global Research and Development (Groton, CT).
February 01, 2002
Participants at a Pharmaceutical Research and Manufacturers of America workshop share their views about the acceptable analytical practices of conducting forced degradation studies.